Determinants of pulmonary vascular resistance reduction with upfront oral therapy in idiopathic pulmonary arterial hypertension: relevance in risk assessment
Event:
ESC Congress 2020
Topic:
Pulmonary Hypertension
Session:
Advances in the Management of Pulmonary Arterial Hypertension